{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:33Z","timestamp":1792787793518,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"SAMWASSM and Gottfried and Julia Bangerter-Rhyner Foundation","award":["YTCR 25\/19."],"award-info":[{"award-number":["YTCR 25\/19."]}]},{"DOI":"10.13039\/501100024075","name":"Region of Southern Denmark","doi-asserted-by":"crossref","award":["journal number 20\/14081"],"award-info":[{"award-number":["journal number 20\/14081"]}],"id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Hypertension is highly prevalent among older people, and the balance of benefit and harm of antihypertensive therapy may shift with age. In certain cases, reducing or discontinuing antihypertensive treatment (deprescribing) may be appropriate. This systematic review and meta-analysis aimed to summarize available evidence on deprescribing antihypertensive medications in older adults aged 65 years and older.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched MEDLINE, Embase, CINAHL, the Cochrane Library, the Web of Science Core Collection, ClinicalTrials.gov, ICTRP and Epistemonikos from inception to July 2024. We included randomized controlled trials (RCTs) and comparative observational studies (OS) comparing deprescribing versus continuation of antihypertensive medications in adults\u2009\u2265\u200965 years. The primary outcome was all-cause mortality. Secondary outcomes included myocardial infarction, heart failure, stroke, major adverse cardiovascular events (MACE), orthostatic hypotension and falls. Where possible, data were synthesized using meta-analysis to estimate odds ratios (ORs) and 95% Confidence Intervals (CI). We assessed the risk of bias in the RCTs in Covidence basing on the Cochrane Risk Of Bias (Rob 2) tool. For the observational studies we used the Newcastle Ottawa Scale for comparative observational studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 17 studies. Results from the observational studies are only reported as narrative summary. The pooled OR for all-cause mortality was 1.11 (95% CI 0.82\u20131.50; 6 RCTs). For secondary outcomes, pooled ORs were 1.32 (95% CI 0.30\u20135.92) for myocardial infarction (3 RCTs), 3.16 (95% CI 1.53\u20136.55) for heart failure (3 RCTs), and 3.08 (95% CI 0.73-13.00) for stroke (4 RCTs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The effects of deprescribing antihypertensive medications in older adults remain uncertain. The limited and low-event-rate evidence on key cardiovascular outcomes for older individuals highlights the need for individualized decision-making, especially in frail and multimorbid populations. This review provides a foundation for future research to address gaps and guide safer deprescribing practices in older adults in routine clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-025-06941-2","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T12:15:39Z","timestamp":1767615339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Deprescribing antihypertensive medications in older people: a systematic review and a meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Carmen","family":"Floriani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Minchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Edith","family":"Schulthess-Lisibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Lundby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja Josephine Lundberg","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Zangger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orestis","family":"Efthimiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enriqueta","family":"Vallejo-Yag\u00fce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Neuner-Jehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Lunny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinde K. E.","family":"Poortvliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobijn","family":"Gussekloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella S.","family":"Daskalopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"von Gernler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Streit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"3","key":"6941_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2165\/00002512-199405030-00003","volume":"5","author":"CJ Bulpitt","year":"1994","unstructured":"Bulpitt CJ, Fletcher AE, Amery A, Coope J, Evans JG, Lightowlers S, et al. The hypertension in the very elderly trial (HYVET). Rationale, methodology and comparison with previous trials. Drugs Aging. 1994;5(3):171\u201383.","journal-title":"Drugs Aging"},{"issue":"2","key":"6941_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/clc.23303","volume":"43","author":"E Oliveros","year":"2020","unstructured":"Oliveros E, Patel H, Kyung S, Fugar S, Goldberg A, Madan N, et al. Hypertension in older adults: Assessment, management, and challenges. Clin Cardiol. 2020;43(2):99\u2013107.","journal-title":"Clin Cardiol"},{"issue":"10022","key":"6941_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure Lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957\u201367.","journal-title":"Lancet"},{"issue":"7","key":"6941_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/CIRCRESAHA.118.313236","volume":"124","author":"A Benetos","year":"2019","unstructured":"Benetos A, Petrovic M, Strandberg T. Hypertension management in older and frail older patients. Circ Res. 2019;124(7):1045\u201360.","journal-title":"Circ Res"},{"issue":"11","key":"6941_CR5","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.jamda.2023.07.016","volume":"24","author":"D Zhou","year":"2023","unstructured":"Zhou D, Chen Z, Tian F. Deprescribing interventions for older patients: A systematic review and Meta-Analysis. J Am Med Dir Assoc. 2023;24(11):1718\u201325.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"6941_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jama.2015.7517","volume":"314","author":"A Benetos","year":"2015","unstructured":"Benetos A, Rossignol P, Cherubini A, Joly L, Grodzicki T, Rajkumar C, et al. Polypharmacy in the aging patient: management of hypertension in octogenarians. JAMA. 2015;314(2):170.","journal-title":"JAMA"},{"issue":"12","key":"6941_CR7","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1001\/jamainternmed.2018.4684","volume":"178","author":"JP Sheppard","year":"2018","unstructured":"Sheppard JP, Stevens S, Stevens R, Martin U, Mant J, Hobbs FDR, et al. Benefits and harms of antihypertensive treatment in Low-Risk patients with mild hypertension. JAMA Intern Med. 2018;178(12):1626.","journal-title":"JAMA Intern Med"},{"issue":"16","key":"6941_CR8","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1001\/jama.2020.16438","volume":"324","author":"WB Applegate","year":"2020","unstructured":"Applegate WB, Williamson JD, Berlowitz D. Deprescribing antihypertensive medication in elderly adults. JAMA. 2020;324(16):1682.","journal-title":"JAMA"},{"issue":"12","key":"6941_CR9","doi-asserted-by":"publisher","first-page":"e061686","DOI":"10.1136\/bmjopen-2022-061686","volume":"12","author":"L Brunner","year":"2022","unstructured":"Brunner L, Rodondi N, Aubert CE. Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review. BMJ Open. 2022;12(12):e061686.","journal-title":"BMJ Open"},{"key":"6941_CR10","first-page":"CD012572","volume":"6","author":"E Reeve","year":"2020","unstructured":"Reeve E, Jordan V, Thompson W, Sawan M, Todd A, Gammie TM, et al. Withdrawal of antihypertensive drugs in older people. Cochrane Database Syst Rev. 2020;6:CD012572.","journal-title":"Cochrane Database Syst Rev"},{"key":"6941_CR11","doi-asserted-by":"publisher","unstructured":"Gnjidic D, Langford AV, Jordan V, Sawan M, Sheppard JP, Thompson W et al. Withdrawal of antihypertensive drugs in older people. Cochrane Central Editorial Service, editor. Cochrane Database Syst Rev. 2025 Mar 31;2025(3). Available from: https:\/\/doi.org\/10.1002\/14651858.CD012572.pub3 . Cited 13 Nov 2025.","DOI":"10.1002\/14651858.CD012572.pub3"},{"key":"6941_CR12","doi-asserted-by":"publisher","unstructured":"Van Poelgeest E, Paoletti L, \u00d6zk\u00f6k S, Pinar E, Bahat G, Vuong V et al. The effects of diuretic deprescribing in adult patients: A systematic review to inform an evidence-based diuretic deprescribing guideline. Br J Clin Pharmacol. 2024;91(1):38\u201354. https:\/\/doi.org\/10.1111\/bcp.16189.","DOI":"10.1111\/bcp.16189"},{"key":"6941_CR13","doi-asserted-by":"publisher","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. editors. Cochrane Handbook for Systematic Reviews of Interventions. 1st ed. Wiley; 2019 [cited 2025 Jan 26]. Available from:\u00a0https:\/\/onlinelibrary.wiley.com\/doi\/book\/\u00a0https:\/\/doi.org\/10.1002\/9781119536604.","DOI":"10.1002\/9781119536604"},{"key":"6941_CR14","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;n71.","DOI":"10.1136\/bmj.n71"},{"issue":"9","key":"6941_CR15","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/sim.1761","volume":"23","author":"J Sweeting","year":"2004","unstructured":"Sweeting J, Sutton MJ, Lambert AC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23(9):1351\u201375.","journal-title":"Stat Med"},{"issue":"1","key":"6941_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/sim.2528","volume":"26","author":"MJ Bradburn","year":"2007","unstructured":"Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007;26(1):53\u201377.","journal-title":"Stat Med"},{"issue":"2","key":"6941_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/eb-2018-102911","volume":"21","author":"O Efthimiou","year":"2018","unstructured":"Efthimiou O. Practical guide to the meta-analysis of rare events. Evid Based Ment Health. 2018;21(2):72\u20136.","journal-title":"Evid Based Ment Health"},{"issue":"7","key":"6941_CR18","doi-asserted-by":"publisher","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","volume":"6","author":"J IntHout","year":"2016","unstructured":"IntHout J, Ioannidis JPA, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016;6(7):e010247.","journal-title":"BMJ Open"},{"issue":"4","key":"6941_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/sim.4780140406","volume":"14","author":"CS Berkey","year":"1995","unstructured":"Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta\u2010analysis. Stat Med. 1995;14(4):395\u2013411.","journal-title":"Stat Med"},{"key":"6941_CR20","doi-asserted-by":"crossref","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;l4898.","DOI":"10.1136\/bmj.l4898"},{"key":"6941_CR21","doi-asserted-by":"crossref","unstructured":"Deeks J, Dinnes J, D\u2019Amico R, Sowden A, Sakarovitch C, Song F et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003 Sep;7(27). Available from: https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta7270\/ . Cited 25 Mar 2025.","DOI":"10.3310\/hta7270"},{"issue":"20","key":"6941_CR22","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","volume":"25","author":"RM Harbord","year":"2006","unstructured":"Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta\u2010analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443\u201357.","journal-title":"Stat Med"},{"issue":"1","key":"6941_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/ageing\/6.1.38","volume":"6","author":"ML Burr","year":"1977","unstructured":"Burr ML, King S, Davies HE, Pathy MS. The effects of discontinuing long-term diuretic therapy in the elderly. Age Ageing. 1977;6(1):38\u201345.","journal-title":"Age Ageing"},{"issue":"8","key":"6941_CR24","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1016\/S2666-7568(24)00131-4","volume":"5","author":"JP Sheppard","year":"2024","unstructured":"Sheppard JP, Temple E, Wang A, Smith A, Pollock S, Ford GA, et al. Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the optimise randomised controlled trial. Lancet Healthy Longev. 2024;5(8):e563\u201373.","journal-title":"Lancet Healthy Longev"},{"issue":"6","key":"6941_CR25","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1111\/1475-6773.13074","volume":"53","author":"W Song","year":"2018","unstructured":"Song W, Intrator O, Lee S, Boockvar K. Antihypertensive drug deintensification and recurrent falls in Long-Term care. Health Serv Res. 2018;53(6):4066\u201386.","journal-title":"Health Serv Res"},{"issue":"9","key":"6941_CR26","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jamda.2018.12.006","volume":"20","author":"JW van Dalen","year":"2019","unstructured":"van Dalen JW, van Moll EP, van Gool WA, Richard E. Discontinuation of antihypertensive Medication, cognitive Complaints, and incident dementia. J Am Med Dir Assoc. 2019;20(9):1091\u2013e10973.","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"6941_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/11.4.213","volume":"11","author":"MG Myers","year":"1982","unstructured":"Myers MG, Weingert ME, Fisher RH, Gryfe CI, Shulman HS. UNNECESSARY DIURETIC THERAPY IN THE ELDERLY. Age Ageing. 1982;11(4):213\u201321.","journal-title":"Age Ageing"},{"issue":"2","key":"6941_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1681\/ASN.2020050682","volume":"32","author":"EL Fu","year":"2021","unstructured":"Fu EL, Evans M, Clase CM, Tomlinson LA, van Diepen M, Dekker FW, et al. Stopping Renin-Angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: A nationwide study. J Am Soc Nephrol JASN. 2021;32(2):424\u201335.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"6","key":"6941_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2165\/00002018-200730060-00008","volume":"30","author":"M Teichert","year":"2007","unstructured":"Teichert M, de Smet PAGM, Hofman A, Witteman JCM, Stricker BHC. Discontinuation of beta-blockers and the risk of myocardial infarction in the elderly. Drug Saf. 2007;30(6):541\u20139.","journal-title":"Drug Saf"},{"issue":"20","key":"6941_CR30","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1001\/jama.2020.4871","volume":"323","author":"JP Sheppard","year":"2020","unstructured":"Sheppard JP, Burt J, Lown M, Temple E, Lowe R, Fraser R, et al. Effect of antihypertensive medication reduction vs usual care on Short-term blood pressure control in patients with hypertension aged 80 years and older: the OPTIMISE randomized clinical trial. JAMA. 2020;323(20):2039.","journal-title":"JAMA"},{"issue":"7106","key":"6941_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/bmj.315.7106.464","volume":"315","author":"EP Walma","year":"1997","unstructured":"Walma EP, Hoes AW, van Dooren C, Prins A, van der Does E. Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial. BMJ. 1997;315(7106):464\u20138.","journal-title":"BMJ"},{"issue":"10","key":"6941_CR32","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1001\/jamainternmed.2015.4103","volume":"175","author":"JEF Moonen","year":"2015","unstructured":"Moonen JEF, Foster-Dingley JC, de Ruijter W, van der Grond J, Bertens AS, van Buchem MA, et al. Effect of discontinuation of antihypertensive treatment in elderly people on cognitive Functioning\u2014the DANTE study leiden: A randomized clinical trial. JAMA Intern Med. 2015;175(10):1622.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"6941_CR33","doi-asserted-by":"publisher","first-page":"030006052211307","DOI":"10.1177\/03000605221130716","volume":"50","author":"S Hasegawa","year":"2022","unstructured":"Hasegawa S, Mizokami F, Mase H, Hayakawa Y, Shimizu A, Matsui Y. Effects of discontinuation of antihypertensive drugs on frailty syndrome in outpatients: a 1-year prospectively designed retrospective chart-review pilot study. J Int Med Res. 2022;50(10):03000605221130716.","journal-title":"J Int Med Res"},{"issue":"12","key":"6941_CR34","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.jacc.2020.01.040","volume":"75","author":"P Nijst","year":"2020","unstructured":"Nijst P, Martens P, Dauw J, Tang WHW, Bertrand PB, Penders J, et al. Withdrawal of neurohumoral Blockade after cardiac resynchronization therapy. J Am Coll Cardiol. 2020;75(12):1426\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"6941_CR35","doi-asserted-by":"publisher","first-page":"afae133","DOI":"10.1093\/ageing\/afae133","volume":"53","author":"JMK Bogaerts","year":"2024","unstructured":"Bogaerts JMK, Gussekloo J, De Jong-Schmit BEM, Le Cessie S, Mooijaart SP, Van Der Mast RC, et al. Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial. Age Ageing. 2024;53(7):afae133.","journal-title":"Age Ageing"},{"issue":"5","key":"6941_CR36","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/jamainternmed.2020.0193","volume":"180","author":"Y Qiao","year":"2020","unstructured":"Qiao Y, Shin JI, Chen TK, Inker LA, Coresh J, Alexander GC, et al. Association between Renin-Angiotensin system Blockade discontinuation and All-Cause mortality among persons with low estimated glomerular filtration rate. JAMA Intern Med. 2020;180(5):718\u201326.","journal-title":"JAMA Intern Med"},{"key":"6941_CR37","doi-asserted-by":"crossref","unstructured":"Aubert CE, Ha J, Kim HM, Rodondi N, Kerr EA, Hofer TP et al. Clinical outcomes of modifying hypertension treatment intensity in older adults treated to low blood pressure. J Am Geriatr Soc. 2021;jgs.17295.","DOI":"10.1111\/jgs.17295"},{"issue":"2","key":"6941_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/ageing\/afv199","volume":"45","author":"JEF Moonen","year":"2016","unstructured":"Moonen JEF, Foster-Dingley JC, de Ruijter W, van der Grond J, de Craen AJM, van der Mast RC. Effect of discontinuation of antihypertensive medication on orthostatic hypotension in older persons with mild cognitive impairment: the DANTE study Leiden. Age Ageing. 2016;45(2):249\u201355.","journal-title":"Age Ageing"},{"issue":"8","key":"6941_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s40266-022-00957-8","volume":"39","author":"MH Duong","year":"2022","unstructured":"Duong MH, Gnjidic D, McLachlan AJ, Sakiris MA, Goyal P, Hilmer SN. The prevalence of adverse drug reactions and adverse drug events from heart failure medications in frail older adults: A systematic review. Drugs Aging. 2022;39(8):631\u201343.","journal-title":"Drugs Aging"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06941-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06941-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06941-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:02:49Z","timestamp":1771488169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-025-06941-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6941"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06941-2","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J S\u00f8ndergaard participated in advisory boards on medical technology for Abbot Rapid Diagnostics a\/s and for Astrazeneca a\/s.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}